WS #16503
Eli Lilly raised full-year guidance on weight-loss drug sales, and Merck beat on Keytruda, reinforcing the strength of the healthcare sector. Baxter and WEC Energy also beat estimates, demonstrating resilience in medical devices and utilities. These beats provide a safe haven for investors rotating out of tech and into defensive, cash-generative sectors with pricing power.
Healthcare and Consumer Beats
Eli Lilly raised full-year guidance on weight-loss drug sales, and Merck beat on Keytruda, reinforcing the strength of the healthcare sector. Baxter and WEC Energy also beat estimates, demonstrating resilience in medical devices and utilities. These beats provide a safe haven for investors rotating out of tech and into defensive, cash-generative sectors with pricing power.